A Validation of the Cantonese Version of the Birmingham Cognitive Screen (BCoS) for Stroke Survivors in Hong Kong

The Birmingham Cognitive Screen (BCoS) is a neuropsychological battery designed to assess impairment to a variety of cognitive domains including language in patients with brain injuries. Twenty-two stroke participants and 16 gender-, age-, and education-matched controls were recruited in Hong Kong. The stroke participants were administered HK-BCoS as well as standardized batteries of cognitive and language functions validated for the Cantonese-speaking population in Hong Kong, including the Cantonese version of the Western Aphasia Battery, Cantonese Mini-Mental State Examination, and the Hong Kong–Montreal Cognitive Assessment. Results showed that HK-BCoS demonstrated good concurrent validity with all standardized batteries. HK-BCoS could discriminate between cognitive impairments in stroke patients and normal participants. Furthermore, HK-BCoS was found to have excellent intrarater and interrater reliabilities, good test–retest reliability, and fair split-half reliability as judged according to international criteria. In sum, HK-BCoS is a valid and reliable tool for assessing cognitive processing in Cantonese speakers in Hong Kong.

Download Full-text

A Comparison of the Long-term Health Related Quality of Life and Handicap of Stroke Patients in Mainland China and Hong Kong

Health Services Insights ◽

10.1177/117863291000300001 ◽

2010 ◽

Vol 3 ◽

pp. 117863291000300

Author(s):

T Kwok ◽

X Jin ◽

F Yeung ◽

J Cheng ◽

RSK Lo ◽

...

Keyword(s):

Quality Of Life ◽

Hong Kong ◽

Mainland China ◽

Stroke Survivors ◽

Health Related Quality ◽

Stroke Patients ◽

Related Factors ◽

Related Quality ◽

Health Related

Purpose To compare health related quality of life (HRQOL) and handicap of stroke survivors in Hong Kong (HK) and Chengdu (CD) in Mainland China. Method Fifty-four pairs of first ever stroke patients in CD and in HK matched by age, sex and Modified Barthel Index (MBI) were interviewed using a structured questionnaire at 16–36 months after stroke. HRQOL and handicap outcomes were evaluated by the Chinese version of the Short-Form Health Survey (SF-36) and London Handicap Scale (LHS) respectively. Results Compared to stroke patients in CD, HK subjects reported significantly greater handicap, especially in the occupation domain. HK subjects also had significantly lower HRQOL Z scores in domains of role limitations due to emotional or physical problems, and bodily pain. CD subjects had more social support, but had more difficulties in meeting medical costs, and were less likely to have regular medical follow-up and dysphagia symptom. After adjusting for social and health related factors, the site differences in handicap and the role limitation (physical) domain of SF36 became insignificant. Conclusions CD stroke survivors had better scores in HRQOL and fewer handicaps than their counterparts in HK, because of social and health related factors.

Download Full-text

FAMILY CAREGIVERS’ AND PATIENTS’ EXPERIENCES WITH FIRST-EVER STROKE SURVIVORS IN HONG KONG: WHAT CONTRIBUTED TO POSITIVE RECOVERY?

The Gerontologist ◽

10.1093/geront/gnv531.03 ◽

2015 ◽

Vol 55 (Suppl_2) ◽

pp. 158-158

Keyword(s):

Hong Kong ◽

Family Caregivers ◽

Stroke Survivors

Download Full-text

The Russian version of the Oxford Cognitive Screen: Validation study on stroke survivors.

Neuropsychology ◽

10.1037/neu0000491 ◽

2019 ◽

Vol 33 (1) ◽

pp. 77-92 ◽

Cited By ~ 3

Author(s):

Maria Shendyapina ◽

Ekaterina Kuzmina ◽

Sergey Kazymaev ◽

Anna Petrova ◽

Nele Demeyere ◽

...

Keyword(s):

Validation Study ◽

Stroke Survivors ◽

Russian Version ◽

Cognitive Screen

Download Full-text

Oxford Cognitive Screen--Hong Kong Version

PsycTESTS Dataset ◽

10.1037/t52498-000 ◽

2016 ◽

Author(s):

Anthony Pak-Hin Kong ◽

Pinky Hiu-Ping Lam ◽

Diana Wai-Lam Ho ◽

Johnny King Lau ◽

Glyn W. Humphreys ◽

...

Keyword(s):

Hong Kong ◽

Cognitive Screen

Download Full-text

Resilience among stroke survivors : the experience of Hong Kong women

10.5353/th_b4501534 ◽

2006 ◽

Author(s):

Esther Oi-wah Chow

Keyword(s):

Hong Kong ◽

Stroke Survivors

Download Full-text

Translation and Initial Validation of the Chinese (Cantonese) Version of Community Integration Measure for Use in Patients with Chronic Stroke

BioMed Research International ◽

10.1155/2014/623836 ◽

2014 ◽

Vol 2014 ◽

pp. 1-7 ◽

Cited By ~ 3

Author(s):

Tai-Wa Liu ◽

Shamay S. M. Ng ◽

Gabriel Y. F. Ng

Keyword(s):

Hong Kong ◽

Factor Structure ◽

Internal Consistency ◽

Community Integration ◽

Chronic Stroke ◽

Stroke Survivors ◽

Retest Reliability ◽

Initial Validation ◽

Integration Measure ◽

Test Retest Reliability

Objectives. To (1) translate and culturally adapt the English version Community Integration Measure into Chinese (Cantonese), (2) report the results of initial validation of the Chinese (Cantonese) version of CIM (CIM-C) including the content validity, internal consistency, test-retest reliability, and factor structure of CIM-C for use in stroke survivors in a Chinese community setting, and (3) investigate the level of community integration of stroke survivors living in Hong Kong.Design. Cross-sectional study.Setting. University-based rehabilitation centre.Participants. 62 (n=62) subjects with chronic stroke.Methods. The CIM-C was produced after forward-backward translation, expert panel review, and pretesting. 25 (n=25) of the same subjects were reassessed after a 1-week interval.Results. The items of the CIM-C demonstrated high internal consistency with a Cronbach’sαof 0.84. The CIM-C showed good test-retest reliability with an intraclass correlation coefficient (ICC) of 0.84 (95% confidence interval, 0.64–0.93). A 3-factor structure of the CIM-C including “relationship and engagement,” “sense of knowing,” and “independent living,” was consistent with the original theoretical model. Hong Kong stroke survivors revealed a high level of community integration as measured by the CIM-C (mean (SD): 43.48 (5.79)).Conclusions. The CIM-C is a valid and reliable measure for clinical use.

Download Full-text